Emerging deep tech like biotechnology and synthetic biology are shaping an exciting new bioeconomy. This CC Innovation Briefing offers a vision for its future, and explains how scalable, profitable and resilient bioprocesses will benefit businesses and sustainability.
Author profile
Rebecca Donaldson
Technology Strategy Consultant for Industrial Biotechnology
As part of the strategy, innovation and process group at Cambridge Consultants, Rebecca helps senior decision makers understand the technology breakthroughs that will have the largest impact on their organisation – and how to capitalise on them.